Canada Markets closed

ESSA Pharma Inc. (EPI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
8.20+0.55 (+7.19%)
At close: 3:58PM EDT
Currency in CAD

Valuation Measures

Market Cap (intraday) 5237.87M
Enterprise Value 3201.48M
Trailing P/E N/A
Forward P/E 1-11.88
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.63
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-9.02

Trading Information

Stock Price History

Beta (5Y Monthly) 1.52
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 311.34
52 Week Low 34.00
50-Day Moving Average 38.20
200-Day Moving Average 38.43

Share Statistics

Avg Vol (3 month) 310.21k
Avg Vol (10 day) 31.4k
Shares Outstanding 529.01M
Float 15.79M
% Held by Insiders 19.49%
% Held by Institutions 170.79%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Apr. 24, 2018

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Sep. 29, 2019
Most Recent Quarter (mrq)Jun. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-61.60%
Return on Equity (ttm)-106.04%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -22.33M
Net Income Avi to Common (ttm)-19.91M
Diluted EPS (ttm)-1.03
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)36.48M
Total Cash Per Share (mrq)1.26
Total Debt (mrq)87.28k
Total Debt/Equity (mrq)0.24
Current Ratio (mrq)29.77
Book Value Per Share (mrq)1.77

Cash Flow Statement

Operating Cash Flow (ttm)-17.7M
Levered Free Cash Flow (ttm)-9.36M